Cargando…
Residual glycosaminoglycan accumulation in mitral and aortic valves of a patient with attenuated MPS I (Scheie syndrome) after 6 years of enzyme replacement therapy: Implications for early diagnosis and therapy
Mucopolysaccharidosis (MPS) is an inherited metabolic disease caused by deficiency of the enzymes needed for glycosaminoglycan (GAG) degradation. MPS type I is caused by the deficiency of the lysosomal enzyme alpha-l-iduronidase and is classified into Hurler syndrome, Scheie syndrome, and Hurler–Sch...
Autores principales: | Sato, Yohei, Fujiwara, Masako, Kobayashi, Hiroshi, Yoshitake, Michio, Hashimoto, Kazuhiro, Oto, Yuji, Ida, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471400/ https://www.ncbi.nlm.nih.gov/pubmed/28649551 http://dx.doi.org/10.1016/j.ymgmr.2015.10.014 |
Ejemplares similares
-
Massive Accumulation of Glycosaminoglycans in the Aortic Valve of a Patient With Hunter Syndrome During Enzyme Replacement Therapy
por: Sato, Yohei, et al.
Publicado: (2013) -
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK
por: Moore, David, et al.
Publicado: (2008) -
Heart valve disease in Hurler-Scheie syndrome
por: del Carmen García del Rey, María, et al.
Publicado: (2022) -
The SCHEIE Visual Field Grading System
por: Sankar, Prithvi S., et al.
Publicado: (2017) -
Longitudinal neurocognitive outcome in an adolescent with Hurler-Scheie syndrome
por: Elkin, T David, et al.
Publicado: (2006)